Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Zhejiang Hisun Pharmaceutical Co. Ltd.

Clinical trials sponsored by Zhejiang Hisun Pharmaceutical Co. Ltd., explained in plain language.

Zhejiang Hisun Pharmaceutical Co. Ltd. 600267 SSE

Pharmaceutical company manufacturing and developing generic and innovative drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

New hope for liver cancer: experimental drug targets tough cases

Disease control Recruiting now

This study tests an experimental drug called AST-3424 in people with advanced liver cancer that has a specific marker (AKR1C3-high) and has worsened after immunotherapy. About 75 participants will receive either AST-3424 or a standard drug (regorafenib) to see which helps them li…

Phase: PHASE2 • Sponsor: Zhejiang Hisun Pharmaceutical Co. Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:07 UTC